Molecular aspects of the FAH mutations involved in HT1 disease

12Citations
Citations of this article
16Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Hereditary tyrosinemia type 1 (HT1) is caused by the lack of fumarylacetoacetate hydrolase (FAH), the last enzyme of the tyrosine catabolic pathway. Up to now, around 100 mutations in the FAH gene have been associated with HT1, and despite many efforts, no clear correlation between genotype and clinical phenotype has been reported. At first, it seems that any mutation in the gene results in HT1. However, placing these mutations in their molecular context allows a better understanding of their possible effects. This chapter presents a closer look at the FAH gene and its corresponding protein in addition to provide a complete record of all the reported mutations causing HT1.

Cite

CITATION STYLE

APA

Morrow, G., Angileri, F., & Tanguay, R. M. (2017). Molecular aspects of the FAH mutations involved in HT1 disease. In Advances in Experimental Medicine and Biology (Vol. 959, pp. 25–48). Springer New York LLC. https://doi.org/10.1007/978-3-319-55780-9_3

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free